← Open Payments lookup

SARAH PETERS: Open Payments

NPI 1710529961 · BELLEVUE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,464 in 112 payments from 23 companies in 2025. Trend: 2023 $1,858 · 2024 $2,850 · 2025 $2,464

Food & beverage: $2,464
CompanyPaymentsAmount
GENZYME CORPORATION30$688
AstraZeneca Pharmaceuticals LP13$385
Regeneron Healthcare Solutions, Inc.10$242
Genentech USA, Inc.7$177
GlaxoSmithKline, LLC.14$144
Takeda Pharmaceuticals U.S.A., Inc.4$110
LEO Pharma Inc.3$85
Novartis Pharmaceuticals Corporation3$63
Optinose US, Inc.3$62
Hikma Pharmaceuticals USA3$58

Products named: DUPIXENT, AIRSUPRA, Xolair, NUCALA, FASENRA, Xhance, ADBRY, Ryaltris.

Industry payments across NE — which companies pay providers there.